270 related articles for article (PubMed ID: 22448735)
1. Development of a rule-based method for the assessment of protein druggability.
Perola E; Herman L; Weiss J
J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
[TBL] [Abstract][Full Text] [Related]
2. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
3. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
Fauman EB; Rai BK; Huang ES
Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
[TBL] [Abstract][Full Text] [Related]
4. Ligand aligning method for molecular docking: alignment of property-weighted vectors.
Joung JY; Nam KY; Cho KH; No KT
J Chem Inf Model; 2012 Apr; 52(4):984-95. PubMed ID: 22471323
[TBL] [Abstract][Full Text] [Related]
5. Drug-like density: a method of quantifying the "bindability" of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank.
Sheridan RP; Maiorov VN; Holloway MK; Cornell WD; Gao YD
J Chem Inf Model; 2010 Nov; 50(11):2029-40. PubMed ID: 20977231
[TBL] [Abstract][Full Text] [Related]
6. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
7. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamics of fragment binding.
Ferenczy GG; Keserű GM
J Chem Inf Model; 2012 Apr; 52(4):1039-45. PubMed ID: 22458364
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening for novel ligands.
Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
[TBL] [Abstract][Full Text] [Related]
10. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs.
Giangreco I; Cosgrove DA; Packer MJ
J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904
[TBL] [Abstract][Full Text] [Related]
11. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
12. NMR in structure-based drug design.
Carneiro MG; Ab E; Theisgen S; Siegal G
Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive identification of "druggable" protein ligand binding sites.
An J; Totrov M; Abagyan R
Genome Inform; 2004; 15(2):31-41. PubMed ID: 15706489
[TBL] [Abstract][Full Text] [Related]
14. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
[TBL] [Abstract][Full Text] [Related]
15. Computational method to identify druggable binding sites that target protein-protein interactions.
Li H; Kasam V; Tautermann CS; Seeliger D; Vaidehi N
J Chem Inf Model; 2014 May; 54(5):1391-400. PubMed ID: 24762202
[TBL] [Abstract][Full Text] [Related]
16. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
Schmidtke P; Barril X
J Med Chem; 2010 Aug; 53(15):5858-67. PubMed ID: 20684613
[TBL] [Abstract][Full Text] [Related]
17. Structure-based target druggability assessment.
Trosset JY; Vodovar N
Methods Mol Biol; 2013; 986():141-64. PubMed ID: 23436411
[TBL] [Abstract][Full Text] [Related]
18. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
Barelier S; Krimm I
Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
[TBL] [Abstract][Full Text] [Related]
19. Combining global and local measures for structure-based druggability predictions.
Volkamer A; Kuhn D; Grombacher T; Rippmann F; Rarey M
J Chem Inf Model; 2012 Feb; 52(2):360-72. PubMed ID: 22148551
[TBL] [Abstract][Full Text] [Related]
20. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
